Search Results - "Dalvin, Lauren A"

Modern treatment of retinoblastoma: A 2020 review by Ancona-Lezama, David, Dalvin, Lauren, Shields, Carol

“…Retinoblastoma management remains complex, requiring individualized treatment based on International Classification of Retinoblastoma (ICRB) staging, germline…”
Get full text

Thiolated Chitosan-carboxymethyl Dextran Nanoparticles: Improving Intravitreal Drug Bioavailability for Retinoblastoma by Dalvin, Lauren A

Get full text

Ophthalmic adverse effects of taxanes: The Mayo Clinic experience by Fortes, Blake H, Liou, Harris, Dalvin, Lauren A

“…Purpose: To investigate ophthalmic side effects of taxanes and compare side effect frequency, requirement for cessation of taxane therapy, visual acuity…”
Get full text

Optical coherence tomography features in vitreoretinal lymphoma compared with non-infectious uveitis by El Zein, Lulwa, Smith, Wendy M, White, Launia J, Hodge, David O, Olsen, Timothy W, Pulido, Jose S, Dalvin, Lauren A

“…Vitreoretinal lymphoma (VRL) is a rare intraocular malignancy that poses a diagnostic challenge due to the non-specific clinical presentation that resembles…”
Get full text

Coats disease in 351 eyes: Analysis of features and outcomes over 45 years (by decade) at a single center by Shields, Carol, Udyaver, Sanika, Dalvin, Lauren, Lim, Li-Anne, Atalay, Hatice, L Khoo, Chloe, Mazloumi, Mehdi, Shields, Jerry

“…Purpose: To assess features and outcomes of Coats disease over 5-decades. Methods: Retrospective review of Coats disease patients at a single center. Features…”
Get full text

Prognostication of uveal melanoma is simple and highly predictive using The Cancer Genome Atlas (TCGA) classification: A review by Shields, Carol, Dalvin, Lauren, Vichitvejpaisal, Pornpattana, Mazloumi, Mehdi, Ganguly, Arupa, Shields, Jerry

“…Purpose: The cancer genome atlas (TCGA) is a comprehensive project supported by the National Cancer Institute (NCI) in the United States to explore molecular…”
Get full text

Conjunctival melanoma with orbital invasion and liver metastasis managed with systemic immune checkpoint inhibitor therapy by Chang, Michael, Lally, Sara, Dalvin, Lauren, Orloff, Marlana, Shields, Carol

“…A 60-year-old Caucasian female was referred for biopsy-proven amelanotic orbito-conjunctival melanoma. Map biopsies revealed residual invasive melanoma on the…”
Get full text

Primary treatment of ocular surface squamous neoplasia with topical interferon alpha-2b: Comparative analysis of outcomes based on original tumor configuration by Shields, Carol, Constantinescu, Alexandru, Paulose, Sefy, Yaghy, Antonio, Dalvin, Lauren, Shields, Jerry, Lally, Sara

“…Purpose: The aim of this study was to evaluate tumor control of OSSN with topical IFNα2b alone based on tumor configuration (flat versus (vs.) dome-shaped)…”
Get full text

Primary Intra-Arterial Chemotherapy for Retinoblastoma in the Intravitreal Chemotherapy Era: Five Years of Experience by Dalvin, Lauren A., Kumari, Mamta, Essuman, Vera Adobea, Shohelly Shipa, Shormin, Ancona-Lezama, David , Lucio-Alvarez, J. Antonio, Jabbour, Pascal, Shields, Carol L.

“…Purpose: To report our 5-year experience with intra-arterial chemotherapy (IAC) in the intravitreal chemotherapy (IvitC) era. Methods: Retrospective review of…”
Get full text

Intraocular manifestations of mycobacterium tuberculosis: A review of the literature by Dalvin, Lauren A, Smith, Wendy M

“…Abstract Mycobacterium tuberculosis : is most commonly associated with pulmonary infection. However, tuberculosis (TB) can also affect the eye. TB can affect…”
Get full text

Neurofibromatosis type-1 with retinal microvascular corkscrew tortuosity by Battiston, Adrian, Dalvin, Lauren, Shields, Carol

Get full text

Malignant transformation of choroidal nevus according to race in 3334 consecutive patients by Marous, Charlotte, Shields, Carol, Yu, Michael, Dalvin, Lauren, Ancona-Lezama, David, Shields, Jerry

“…Purpose: To evaluate choroidal nevus demographics, clinical features, imaging features, and the rate of transformation into melanoma by race. Methods: In this…”
Get full text

Busulfan Treatment for Myeloproliferative Disease may Reduce Injection Burden in Vascular Endothelial Growth Factor-Driven Retinopathy by Dalvin, Lauren A., Olsen, Timothy W., Bakri, Sophie J., McCullough, Kristen, Tefferi, Ayalew, Al-Kali, Aref

“…Myeloproliferative neoplasms (MPNs) have been associated with increased systemic levels of vascular endothelial growth factor (VEGF). This study investigated…”
Get full text

Predicting Choroidal Nevus Transformation to Melanoma Using Machine Learning by Tailor, Prashant D., Kopinski, Piotr K., D’Souza, Haley S., Leske, David A., Olsen, Timothy W., Shields, Carol L., Shields, Jerry A., Dalvin, Lauren A.

“…To develop and validate machine learning (ML) models to predict choroidal nevus transformation to melanoma based on multimodal imaging at initial presentation…”
Get full text

Necrotizing Subconjunctival Granulomata and Intraoperative Use of Topical GenTeal Gel by Dalvin, Lauren A., MD, Garcia, Maria D., BA, Salomão, Diva R., MD, Iezzi, Raymond, MD, Barkmeier, Andrew J., MD

Get full text

Photodynamic Therapy in Ocular Oncology by Mazloumi, Mehdi, Dalvin, Lauren A, Abtahi, Seyed-Hossein, Yavari, Negin, Yaghy, Antonio, Mashayekhi, Arman, Shields, Jerry A, Shields, Carol L

“…Over the past two decades, we have witnessed the increasing use of photodynamic therapy (PDT) in the field of ocular oncology. Based on a review of the…”
Get full text

Outcomes of neonatal retinoblastoma in pre-chemotherapy and chemotherapy eras by Camp, David, Dalvin, Lauren, Schwendeman, Rachel, Lim, Li-Anne, Shields, Carol

“…Purpose: To quantify outcomes for neonatal retinoblastoma patients treated during the pre-chemotherapy (1980-1994) and chemotherapy (1995-2018) eras. Methods:…”
Get full text

Personalized medicine in ocular oncology: a brighter future for eye cancer care by Dalvin, Lauren A.

Get full text

Retinal elevation in an infant by Yaghy, Antonio, Dalvin, Lauren, Shields, Carol

Get full text

250 A Living Library for Uveal Melanoma by Dalvin, Lauren A., Erickson, Samantha R., Pfannkoch, Cynthia M., Miley, David R., Salomao, Diva R., Fautsch, Michael P., Markovic, Svetomir N., Fernandez-Zapico, Martin E.

“…OBJECTIVES/GOALS: Overall response rates for metastatic uveal melanoma (UM), regardless of treatment modality, are less than 20%, highlighting an urgent need…”
Get full text